Haemonetics
HAE
HAE
294 hedge funds and large institutions have $3.9B invested in Haemonetics in 2022 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 103 increasing their positions, 104 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.32% less ownership
Funds ownership: 100.85% → 99.53% (-1.3%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
56% less call options, than puts
Call options by funds: $3.35M | Put options by funds: $7.67M
Holders
294
Holding in Top 10
2
Calls
$3.35M
Puts
$7.67M
Top Buyers
| 1 | +$47.2M | |
| 2 | +$35.7M | |
| 3 | +$26.3M | |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$17.2M |
| 5 |
Goldman Sachs
New York
|
+$8.51M |
Top Sellers
| 1 | -$105M | |
| 2 | -$37.2M | |
| 3 | -$26M | |
| 4 |
Millennium Management
New York
|
-$24.6M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$18M |